ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Internal Medicine

Top Internal Medicine Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN SCOLA M.D.

Internal Medicine

536

$19K

162
137 are 65+

46%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $56

SHARON GITTZUS A.N.P.-C

Internal Medicine

533

$28.7K

123
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $56

MEGHAN YORK M.D.

Internal Medicine

532

$25.9K

93
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $56

BRIAN BERGMARK MD

Internal Medicine

530

$35.2K

39
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $56

MEGHAN SHEA M.D.

Internal Medicine

524

$27.2K

36
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $56

VOLODYMYR LYUBCHIK MD

Internal Medicine

524

$17.1K

112
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$33
Average prescription price

Avg: $56

RODRIGO TIRADO M.D.

Internal Medicine

519

$43.8K

117
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$84
Average prescription price

Avg: $56

DOUGLAS GROVES M.D.

Internal Medicine

513

$15K

293
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$29
Average prescription price

Avg: $56

SUCHISMITA REED D.O.

Internal Medicine

512

$17.2K

82
47 are 65+

26%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $56

STEPHANIE MAXIMOUS M.D.

Internal Medicine

511

$18.9K

24
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $56

EILEEN SCULLY M.D., PH.D.

Internal Medicine

510

$242K

19
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 22%

$475
Average prescription price

Avg: $56

CLARA JONES

Internal Medicine

510

$96.4K

100
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

78%
prescriptions for brand name drugs

Avg: 22%

$189
Average prescription price

Avg: $56

ELLIOTT ANDERSON MD

Internal Medicine

503

$159K

97
77 are 65+

22%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$315
Average prescription price

Avg: $56

JUAN HUANUCO PEREZ M.D.

Internal Medicine

503

$17.3K

70
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $56

YUHENG RUAN M.D.

Internal Medicine

501

$25.4K

67
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $56

JOSEPH COCOZZELLA M.D.

Internal Medicine

498

$21.9K

48
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

SUZANNE CHAN M.D., PH. D.

Internal Medicine

493

$17.6K

58
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $56

JOEL SAWADY MD

Internal Medicine

493

$23K

67
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $56

KATE KOPLAN M.D.

Internal Medicine

492

$14.6K

85
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$30
Average prescription price

Avg: $56

STEVEN KAPPLER M.D.

Internal Medicine

480

$68.6K

186
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 22%

$143
Average prescription price

Avg: $56

KURT FABRICK M.D., M.P.H.

Internal Medicine

479

$76.8K

72
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

94%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 22%

$160
Average prescription price

Avg: $56

DOUGLAS KATZ MD

Internal Medicine

471

$8,342

297
138 are 65+

24%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 22%

$18
Average prescription price

Avg: $56

MARY MCNAUGHTON-COLLINS MD

Internal Medicine

470

$28.6K

60
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $56

LORKY LIBARIDIAN M.D.

Internal Medicine

462

$18.3K

71
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $56

YOSEF GLASSMAN M.D.

Internal Medicine

456

$18.8K

107
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank